BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 10912165)

  • 1. [Recent fluoroquinolones. Highly effective weapons for ambulatory therapy].
    Stahlmann R; Lode H
    MMW Fortschr Med; 1999 Nov; 141(47):35-6. PubMed ID: 10912165
    [No Abstract]   [Full Text] [Related]  

  • 2. [Respiratory tract infections. Increasingly more established antibiotics fail].
    MMW Fortschr Med; 2002 Oct; 144(42):65. PubMed ID: 12534005
    [No Abstract]   [Full Text] [Related]  

  • 3. [Oral fluoroquinolones. Rational antibiosis as needed].
    MMW Fortschr Med; 1999 Sep; 141(35):58-9. PubMed ID: 10897964
    [No Abstract]   [Full Text] [Related]  

  • 4. [Fluoroquinolones--a current review].
    Christ W; Kemmler H
    Med Monatsschr Pharm; 2001 Jul; 24(7):215-25. PubMed ID: 11486553
    [No Abstract]   [Full Text] [Related]  

  • 5. The fluoroquinolones after ciprofloxacin and ofloxacin.
    Hooper DC
    Curr Clin Top Infect Dis; 2000; 20():63-91. PubMed ID: 10943519
    [No Abstract]   [Full Text] [Related]  

  • 6. [Moxifloxacin--a novel antimicrobial preparation for treatment of respiratory infections].
    Iakovlev SV; Polushkina NR; Iakovlev VP
    Ter Arkh; 2001; 73(11):15-22. PubMed ID: 11806197
    [No Abstract]   [Full Text] [Related]  

  • 7. Prescribing considerations in fluoroquinolone therapy.
    Gentry LO
    Pharmacotherapy; 1993; 13(2 Pt 2):39S-44S. PubMed ID: 8474937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment in general practice. Effective, well tolerated therapy].
    MMW Fortschr Med; 2000 Sep; 142(37):58-9. PubMed ID: 11026226
    [No Abstract]   [Full Text] [Related]  

  • 9. Fluoroquinolones.
    Molavi A
    Am Fam Physician; 1988 May; 37(5):279-84. PubMed ID: 3284309
    [No Abstract]   [Full Text] [Related]  

  • 10. New uses for new and old quinolones and the challenge of resistance.
    Hooper DC
    Clin Infect Dis; 2000 Feb; 30(2):243-54. PubMed ID: 10671323
    [No Abstract]   [Full Text] [Related]  

  • 11. Choosing the ideal antibiotic therapy and the role of the newer fluoroquinolones in respiratory tract infections.
    Owens RC
    Am J Manag Care; 2000 May; 6(8 Suppl):S442-7. PubMed ID: 10977484
    [No Abstract]   [Full Text] [Related]  

  • 12. Activity of levofloxacin, ofloxacin, D-ofloxacin and ciprofloxacin against systemic and respiratory tract infections in laboratory animals.
    Klesel N; Geweniger KH; Koletzki P; Isert D; Limbert M; Markus A; Riess G; Schramm H; Seibert G; Iyer P
    Drugs; 1995; 49 Suppl 2():211-4. PubMed ID: 8549307
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of the fluoroquinolones in primary care practice.
    Harding GK
    Clin Invest Med; 1989 Feb; 12(1):71-3. PubMed ID: 2920484
    [No Abstract]   [Full Text] [Related]  

  • 14. [Other communal respiratory pathogens and new fluoroquinolones].
    Cantón R; Loza E; Valdezate S; Baquero F
    Enferm Infecc Microbiol Clin; 1998 Dec; 16 Suppl 2():12-21; discussion 47-52. PubMed ID: 10344094
    [No Abstract]   [Full Text] [Related]  

  • 15. [Tested and new chemotherapy in infectious diseases].
    Hoigné R; Keller MF
    Schweiz Med Wochenschr; 1972 Jul; 102(27):933-40. PubMed ID: 4558901
    [No Abstract]   [Full Text] [Related]  

  • 16. Newer fluoroquinolones and the management of respiratory tract infections.
    Karchmer AW
    Clin Infect Dis; 2000 Aug; 31 Suppl 2():S15. PubMed ID: 10984322
    [No Abstract]   [Full Text] [Related]  

  • 17. Respiratory fluoroquinolones: differences in the details.
    Mandell LA; Iannini PB; Tillotson GS
    Clin Infect Dis; 2004 May; 38(9):1331-2; author reply 1332-3. PubMed ID: 15127351
    [No Abstract]   [Full Text] [Related]  

  • 18. [Experiences with septrin therapy of severe bacterial respiratory infections].
    Sassy-Dobray G; Miczbán I; Katona K; Lukács J; Gyöngyösi I; Sebök L
    Orv Hetil; 1971 Dec; 112(51):3073-7. PubMed ID: 5136650
    [No Abstract]   [Full Text] [Related]  

  • 19. Treating respiratory tract infections in ambulatory care in Belgium: fluoroquinolone consumption and resistance development.
    Simoens S; Verhaegen J; Laekeman G; Peetermans WE
    Int J Antimicrob Agents; 2005 Jul; 26(1):62-8. PubMed ID: 15963695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Significant role of newer quinolone antimicrobials in respiratory tract infection: focused on sparfloxacin].
    Jpn J Antibiot; 1994 Oct; 47(10):1241-58. PubMed ID: 7807686
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.